Langenberger B, Baier N, Hanke FC, Fahrentholz J, Gorny C, Sehlen S, Reber KC, Liersch S, Radomski R, Haftenberger J, Busse R, Vogt V, Heppner HJ (2022)
Publication Type: Journal article
Publication year: 2022
Book Volume: 9
Pages Range: 1477-1485
Journal Issue: 2
DOI: 10.1002/nop2.1146
Aim: To estimate the cost-effectiveness of an intervention facilitating the early detection of adverse drug events through the means of health professional training and the application of a digital screening tool. Design: Multi-centred non-randomized controlled trial from August 2018 to March 2020 including 65 nursing homes or home care providers. Methods: We aim to estimate the effect of the intervention on the rate of adverse drug events as primary outcome through a quasi-experimental empirical study design. As secondary outcomes, we use hospital admissions and falls. All outcomes will be measured on patient-month level. Once the causal effect of the intervention is estimated, cost-effectiveness will be calculated. For cost-effectiveness, we include all patient costs observed by the German statutory health insurance. Results: The results of this study will inform about the cost-effectiveness of the optimized drug supply intervention and provide evidence for potential reimbursement within the German statutory health insurance system.
APA:
Langenberger, B., Baier, N., Hanke, F.-C., Fahrentholz, J., Gorny, C., Sehlen, S.,... Heppner, H.J. (2022). The detection and prevention of adverse drug events in nursing home and home care patients: Study protocol of a quasi-experimental study. Nursing Open, 9(2), 1477-1485. https://doi.org/10.1002/nop2.1146
MLA:
Langenberger, Benedikt, et al. "The detection and prevention of adverse drug events in nursing home and home care patients: Study protocol of a quasi-experimental study." Nursing Open 9.2 (2022): 1477-1485.
BibTeX: Download